Skip to content
Saturday 8 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,901.09
+0.31%
DAX
26,319.45
+0.69%
CAC 40
8,714.93
+0.17%
STOXX 50
6,523.86
+0.33%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

weight loss drugs

  • Terry Smith dubs weight-loss giant Novo Nordisk ‘investment disaster’

    Investing

    Star stockpicker Terry Smith has dubbed weight-loss giant Novo Nordisk an “investment disaster” less than two years after he dumped his entire Diageo stake over fears that GLP-1 users would ditch alcohol.  The veteran investment manager, who runs the Fundsmith Equity fund, has said that he regrets his investment in the Danish pharmaceutical firm.  “Novo [...]

    Terry Smith, founder of Fundsmith, speaking at a business conference, wearing a suit and tie, with a focused expression.
  • Cranswick: Pig farmer pivots to bite-sized falafels as Brits embrace weight loss trend

    Retail

    A food conglomerate founded by pig farmers has been rewarded by its expansion into share-sized Mediterranean foods as weight-loss jabs and health kicks surge in popularity. Cranswick was established by a group of Yorkshire pig farmers in 1972, but has since expanded into falafel and houmous with its acquisitions of Mediterranean food brands like Ramona’s [...]

    Cranswick headquarters building exterior with company logo prominently displayed against a clear blue sky
  • Holland & Barrett bets on high street with public health pivot

    Retail

    Holland & Barrett is mounting a renewed focus on its high street presence, offering free health drop-ins amid growing online misinformation and an “under pressure” NHS. The health foods retailer has faced huge losses in recent years and its new chief executive is battling to raise the profile of its high street stores. Anthony Houghton, [...]

    Untitled design showcasing a business meeting with diverse professionals discussing a strategic plan in a modern conferenc...
  • Weight-loss drugs to slow supermarket sales

    February 25, 2026

    Weight-loss drugs are set to slim down supermarket sales in the UK as more Brits opt for diet-conscious shopping, a City broker has warned.  The growth rate of supermarket sales is expected to slow this year due to the increasing popularity of diet-suppressant jabs, population growth and falling food inflation, according to a note from [...]

  • No-zempic: Jolly Brits swap weight-loss jabs for stuffing this Christmas

    December 9, 2025

    Brits are set to go all out this Christmas as nearly half plan to swap out their weight loss jabs for an extra helping of turkey and pudding. One in three don’t plan to return to their normal dose until after New Year in order to take full advantage of the festive season, according to [...]

  • Weight-loss drugs ‘fundamentally changing’ the way Brits eat

    December 3, 2025

    The rise of weight-loss drugs is starting to affect supermarket sales, with experts warning that the sector is unprepared for the change this Christmas. More than one in ten Brits is set to host someone on GLP-1 medication this year, prompting less alcohol and fewer sweets on the menu. “There is a worry that Christmas [...]

  • Mounjaro sales help almost double Ely Lilly’s UK turnover

    September 18, 2025

    The sale of weight loss drug Mounjaro has boosted the UK turnover of pharmaceuticals giant Eli Lilly by 90 per cent during its latest financial year, it has been revealed. The division of the US group has posted a turnover of £889m for 2024, according to new accounts filed with Companies House. The new total [...]

  • Ozempic sales surge as priced-out Mounjaro patients seek cheaper alternative

    August 18, 2025

    Ozempic sales have risen five-fold after a 126 per cent rise in the price of the Mounjaro drug due to pressure from US President Donald Trump.  Mounjaro, manufactured by U.S. pharma giant Eli Lilly, has been the UK’s most popular weight loss jab, prescribed to an estimated 90 per cent of the country’s patients.  But around [...]

Trending Articles

  • WPP slashes jobs as revenue continues to fall

  • Liverpool owners tipped to sell – but not to Amazon boss Bezos – by former CEO

  • Revolut founder’s wealth set to balloon amid talks of share award at $500bn valuation

  • Starling plans to ‘come out swinging’ in diversification bid

  • As it happened: Stocks rise despite new tensions in Strait of Hormuz; Oil price climbs

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook